Quick Answer
BIO-RAD LABORATORIES, INC. reported Diluted EPS of $27.85 per share for fiscal year 2025.
BIO-RAD LABORATORIES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $27.85 | +142.6% |
| 2024 | -$65.36 | -199.5% |
| 2023 | -$21.82 | +82.1% |
| 2022 | -$121.79 | -186.5% |
| 2021 | $140.83 | +11.4% |
| 2020 | $126.47 | +117.0% |
| 2019 | $58.27 | +381.6% |
| 2018 | $12.10 | +197.3% |
| 2017 | $4.07 | +362.5% |
| 2016 | $0.88 | -76.3% |
| 2015 | $3.71 | +21.6% |
| 2014 | $3.05 | +13.4% |
| 2013 | $2.69 | -53.5% |
| 2012 | $5.78 | -8.1% |
| 2011 | $6.29 | -4.6% |
| 2010 | $6.59 | +26.7% |
| 2009 | $5.20 | +60.5% |
| 2008 | $3.24 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.70 | -154.4% | -208.8% |
| June 30, 2025 | $11.67 | +115.3% | +409.6% |
| March 31, 2025 | $2.29 | -83.0% | -90.2% |
| September 30, 2024 | $23.34 | +541.2% | +130.6% |
| June 30, 2024 | -$76.26 | -92.6% | -667.0% |
| March 31, 2024 | $13.45 | +479.7% | +269.5% |
| September 30, 2023 | $3.64 | +166.4% | +109.2% |
| June 30, 2023 | -$39.59 | -27.2% | -1806.5% |
- BIO-RAD LABORATORIES, INC. showed an increase of +142.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, BIO-RAD LABORATORIES, INC.’s diluted eps has grown by 759.6% (from $3.24 per share to $27.85 per share).
- The most recent figure is from BIO-RAD LABORATORIES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: